Adeno-associated virus (AAV) serotype 8 sequences, vectors...

Details Adeno-associated virus (AAV) serotype 8 sequences, vectors... Adeno-associated virus (AAV) serotype 8 sequences, vectors...

2007-10-16

2007-10-16

Guzo, David (Department: 1636)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

C424S093100, C424S093600, C435S320100, C435S235100, C435S069100, C435S069600, C435S325000, C435S455000, C435S456000, C530S350000, C530S324000, C530S325000, C530S326000, C530S327000, C530S328000

Reexamination Certificate

active

10423704

ABSTRACT:
Sequences of a serotype 8 adeno-associated virus and vectors and host cells containing these sequences are provided. Also described are methods of using such host cells and vectors in production of rAAV particles. rAAV8-mediated delivery of therapeutic and immunogenic genes, including Factor VIII, is also provided.

REFERENCES:
patent: 5866552 (1999-02-01), Wilson et al.
patent: 5871982 (1999-02-01), Wilson et al.
patent: 6156303 (2000-12-01), Russell et al.
patent: 6251677 (2001-06-01), Wilson et al.
patent: 6258595 (2001-07-01), Gao et al.
patent: 6274354 (2001-08-01), Wilson et al.
patent: 6312957 (2001-11-01), Einerhand et al.
patent: 6365394 (2002-04-01), Gao et al.
patent: 6387368 (2002-05-01), Wilson et al.
patent: 6399385 (2002-06-01), Croyle et al.
patent: 6428988 (2002-08-01), Wilson et al.
patent: 6468524 (2002-10-01), Chiorini et al.
patent: 6475769 (2002-11-01), Wilson et al.
patent: 6482634 (2002-11-01), Wilson et al.
patent: 6485966 (2002-11-01), Gao et al.
patent: 6759237 (2004-07-01), Wilson et al.
patent: 6821512 (2004-11-01), Gao et al.
patent: 2001/0006955 (2001-07-01), Wilson et al.
patent: 2002/0037867 (2002-03-01), Wilson et al.
patent: 2002/0090717 (2002-07-01), Guangping Gao et al.
patent: 2003/0040101 (2003-02-01), Wilson et al.
patent: 2003/0073232 (2003-04-01), Wilson et al.
patent: 2003/0119191 (2003-06-01), Gao et al.
patent: 2003/0138772 (2003-07-01), Gao et al.
patent: 2004/0052764 (2004-03-01), Hildinger et al.
patent: 1 310 571 (2003-05-01), None
patent: WO96/00587 (1996-01-01), None
patent: WO96/13598 (1996-05-01), None
patent: WO 98/09657 (1998-03-01), None
patent: WO 98/10086 (1998-03-01), None
patent: WO 98/10088 (1998-03-01), None
patent: WO98/11244 (1998-03-01), None
patent: WO 99/14354 (1999-03-01), None
patent: WO 99/15677 (1999-04-01), None
patent: WO 99/15685 (1999-04-01), None
patent: WO 99/47691 (1999-09-01), None
patent: WO 99/61601 (1999-12-01), None
patent: WO 00/28061 (2000-05-01), None
patent: WO 00/75353 (2000-12-01), None
patent: WO 01/23001 (2001-04-01), None
patent: WO 01/23597 (2001-04-01), None
patent: WO 01/40455 (2001-06-01), None
patent: WO 01/70276 (2001-09-01), None
patent: WO 01/83692 (2001-11-01), None
patent: WO 02/18659 (2002-03-01), None
patent: WO 03/104392 (2003-12-01), None
Rick et al, Congenital Bleeding Disorders, American Society of Hematology, pp. 559-574 (2003).
Gao et al, Erythropoietin Gene Therapy Leads to Autoimmune Anemia in Macaques, Blood, vol. 103, No. 9, (May 1, 2004).
Gao et al, Clades of Adeno-Associated Viruses are Widely Disseminated in Human Tissues, Journal of Virology, vol. 78, No. 12, pp. 6381-6388 (Jun. 2004).
Lebherz et al, Gene Therapy with Novel Adeno-Associated Virus Vectors Substantially Diminishes Atherosclerosis in a Murine Model of Familial Hypercholesterolemia, The Journal of Gene Medicine, vol. 6 No. 6, pp. 663-672 (Jun. 2004).
Sarkar et al, Total Correction of Hemophilia A Mice with Canine FVIII Using An AAV 8 Serotype, Blood First Edition Paper, (Oct. 9, 2003).
Gao, Guangping et al, Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy, PNAS, vol. 99, No. 18, pp. 11854-11859, (Sep. 3, 2002).
Xiao, Weidong et al, Gene Therapy Vectors Based on Adeno-Associated Virus Type I, Journal of Virology, vol. 73, No. 5, pp. 3994-4003, (May 1999) XP-002137090.
Rutledge, Elizabeth et al, Infectious Clones and Vectors Derived form Adeno-Associated Virus (AAV) Serotypes Other than AAV Type 2, Journal Of Virology, vol. 72, No. 1, pp. 309-319, (Jan. 1998) XP-002137089.
Xiao, Xiao et al, Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Adenovirus, vol. 72, No. 3, pp. 2224-2232, (Mar. 1998) XP002924402.
Bantel-Schaal, Human Adeno-Associated Virus Type 5 Is only Distantly Related to Other known primate helper-dependent parvoviruses, Journal of Virology, vol. 73, No. 2, pp. 939-947, (Feb. 1999).
Forslund et al, A Broad Range of Human Papillomavirus Types Detected with a General PCR Method Suitable for Analysis of Cutaneous Tumours and Normal Skin, Journal of General Virology, vol. 80, No. 9, pp. 2437-2443, XP002229850, (Sep. 9, 1999).
Chirmule et al, “Humoral Immunity to Adeno-Associated Virus Type 2 Vectors following Administration to Murine and Nonhuman Primate Muscle”, Journal of Virology, vol. 74, No. 5, pp. 2420-2425 (Mar. 2000).
Lu et al, Analysis of Homologous Recombination Between different AAV Genomes in In Vitro Co-Infections, Molecular Therapy, vol. 7, No. 5, Abstract 38. pp. S15, (May 2003).
Vandenberghe et al, Structure-Function Relationship of the Novel Non-Human Primate Adeno-Associated Viruses, Molecular Therapy, vol. 7, No. 5, Abstract 99. pp. S40, (May 2003).
Calcedo et al, Serologic Characterization of Human and Non-Human Primate AAVs, Molecular Therapy, vol. 7, No. 5, Abstract 102. pp. S41, (May 2003).
Gao et al, Diversity of Latent AAV Genomes in Non-Human Primate and Human Tissues, Molecular Therapy, vol. 7, No. 5, Abstract 400. pp. S158, (May 2003).
Wang et al, Production of AAV Vectors with Different Serotypes, Molecular Therapy, vol. 7, No. 5, Abstract 906. pp. S350, (May 2003).
Zhou et al, Direct Rescue and Cloning of Infectious Novel AAV Genomes from Non-Human Primate Tissues, Molecular Therapy, vol. 7, No. 5, Abstract 907. pp. S350, (May 2003).
Sanmiguel et al, Real-Time PCR as an Analytic Tool in Gene Therapy, Molecular Therapy, vol. 7, No. 5, Abstract 913. pp. S352, (May 2003).
Zhou et al, Evaluation of Novel Gene Transfer Vectors Derived from Infectious Molecular Clones of Primate AAVs, 7thAnnual Meeting of The American Society of Gene Therapy [Jun. 2-6, 2004] Minneapolis, Minnesota, Abstract 90, (e-publ. May 2, 2004).
Vandenberghe et al, AAV Clades: Their Ability to Recombine and cross Species-Barriers, 7thAnnual Meeting of The American Society of Gene Therapy [Jun. 2-6, 2004] Minneapolis, Minnesota, Abstract 88, (e-publ. May 2, 2004).
De et al, Therapeutic Levels for α 1-Antitrypsin Following Intrapleural Administration of a Non-human Primate Serotype rh10 AAV Vector Expressing α 1-Antitrypsin, 7thAnnual Meeting of The American Society of Gene Therapy [Jun. 2-6, 2004] Minneapolis, Minnesota, Abstract 338, (e-publ. May 2, 2004).
Limberis et al, A Novel AAV Vector for the Treatment of Cystic Fibrosis Airway Disease, 7thAnnual Meeting of The American Society of Gene Therapy [Jun. 2-6, 2004] Minneapolis, Minnesota, Abstract 692, (e-publ. May 2, 2004).
Sun et al, Efficacy of an Adeno-Associated Virus 8-Pseudotyped Vector in Glycogen Storage Disease Type II, Molecular Therapy, vol. 11, No. 1, pp. 57-65, (Jan. 2005).
Mizukami at al, AAV8-Mediated Transgene Expression in Mice and Non-Human Primates, American Society of Gene Therapy, 9thAnnual Meeting, Abstract, (May 31-Jun. 4, 2006).

Affiliated with

Also associated with

Rating

Adeno-associated virus (AAV) serotype 8 sequences, vectors... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adeno-associated virus (AAV) serotype 8 sequences, vectors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adeno-associated virus (AAV) serotype 8 sequences, vectors... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3885052